Hypothesis

Aging‑associated microglial activation releases extracellular vesicles (exosomes) that contain both oxidized mitochondrial DNA (ox‑mtDNA) and specific microRNAs (miR‑34a‑5p, miR‑146a‑5p). These exosomes are taken up by neurons, where the ox‑mtDNA activates cGAS‑STING signaling, while the delivered miRNAs suppress the expression of SIRT3 and promote S‑nitrosylation of OGG1 and APE1. The combined effect leads to post‑translational inactivation of neuronal base excision repair (BER) enzymes, causing accumulation of 8‑oxoguanine (8‑oxoG) and exacerbating neuroinflammation and cognitive decline.

Mechanistic Reasoning

1. Microglial exosome cargo – Recent work shows microglia‑derived EVs transfer ox‑mtDNA that triggers cGAS‑STING in neurons [https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.4c00160]. Aging microglia also increase secretion of miR‑34a‑5p and miR‑146a‑5p, which target SIRT3 mRNA [https://pmc.ncbi.nlm.nih.gov/articles/PMC10247526/].
2. SIRT3 loss and protein nitrosylation – SIRT3 deacetylates and activates mitochondrial OGG1; its decline leads to hyperacetylation and reduced OGG1 activity [https://www.alzdiscovery.org/uploads/cognitive_vitality_media/OGG1_Agonists.pdf]. Concurrently, oxidative stress elevates nitric oxide, promoting S‑nitrosylation of cysteine residues in OGG1 and APE1, directly inhibiting their catalytic activity [https://pmc.ncbi.nlm.nih.gov/articles/PMC3834072/].
3. Feed‑forward loop – cGAS‑STING activation drives type‑I interferon production, further stimulating microglial activation and exosome release, creating a vicious cycle that amplifies neuronal BER suppression.

Testable Predictions

• Prediction 1: In aged mice, neuronal extracts will show elevated S‑nitrosylated OGG1/APE1 and reduced SIRT3 levels correlated with increased microglial exosome markers (CD63, TSG101) in the hippocampus.
• Prediction 2: Pharmacological inhibition of exosome release (e.g., GW4869) or neutralization of miR‑34a‑5p/miR‑146a‑5p with antagomirs will restore SIRT3 expression, decrease OGG1/APE1 nitrosylation, lower 8‑oxoG levels, and improve cognitive performance in aged wild‑type mice.
• Prediction 3: Neurons exposed to microglia‑derived exosomes from aged donors will exhibit increased cGAS‑STING signaling, SIRT3 downregulation, and OGG1/APE1 S‑nitrosylation; these effects will be blocked by exosome depletion or SIRT3 overexpression.

Experimental Approach

1. Isolation and characterization – Collect exosomes from microglia of young (3 mo) and aged (24 mo) mice; quantify ox‑mtDNA (qPCR for 8‑oxoG‑mtDNA) and miR‑34a‑5p/miR‑146a‑5p (small‑RNA seq).
2. Neuronal treatment – Apply purified exosomes to primary cortical neurons; measure SIRT3 protein (Western blot), OGG1/APE1 S‑nitrosylation (biotin‑switch assay), BER activity (OGG1 incision assay), and 8‑oxoG accumulation (immunofluorescence or slot‑blot).
3. In vivo validation – Treat aged mice intracerebroventricularly with GW4869 or miR antagomirs for 4 weeks; assess neuronal BER markers, cognitive behavior (Morris water maze), and neuroinflammation (Iba1, IFN‑β).
4. Rescue experiments – Overexpress SIRT3 via AAV in neurons of exosome‑treated mice to determine whether restoring SIRT3 reverses OGG1/APE1 inactivation.

Potential Outcomes and Falsification

• Supportive outcome: Exosome inhibition or miRNA antagomir treatment normalizes SIRT3, reduces OGG1/APE1 nitrosylation, lowers 8‑oxoG, and rescues cognition.
• Refuting outcome: No change in neuronal BER parameters despite successful exosome blockade, or SIRT3 manipulation fails to affect OGG1/APE1 activity, would falsify the proposed miRNA‑SIRT3‑nitrosylation axis.

Implications

If validated, this hypothesis positions microglial exosomes as a non‑cell‑autonomous conduit that couples inflammatory signaling to direct enzymatic sabotage of neuronal BER. It suggests combinatorial therapies—exosome release inhibitors, miRNA antagonists, and SIRT3 activators—as a promising strategy to counteract age‑related BER decline and neurodegenerative pathology.